Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

[1] Agoff SN(2003)Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations Am J Clin Pathol 120 725-731

[2] Swanson PE(2006)Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells Mol Cancer Ther 5 1539-1549

[3] Linden H(1995)Androgens induce divergent proliferative responses in human breast cancer cell lines J Steroid Biochem Mol Biol 52 459-467

[4] Hawes SE(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502

[5] Lawton TJ(2010)Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers Breast Cancer Res Treat 124 607-617

[6] Bhattacharyya RS(2015)Targeting the androgen receptor in breast cancer Curr Oncol Rep 17 4-89

[7] Krishnan AV(2015)Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer Ann Surg Oncol 22 82-243

[8] Swami S(2008)Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors J Steroid Biochem Mol Biol 110 236-11

[9] Feldman D(2010)Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells Breast Cancer Res Treat 121 1-4008

[10] Birrell SN(2006)An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen Oncogene 25 3994-15

[1] Agoff SN(2003)Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations Am J Clin Pathol 120 725-731

[2] Swanson PE(2006)Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells Mol Cancer Ther 5 1539-1549

[3] Linden H(1995)Androgens induce divergent proliferative responses in human breast cancer cell lines J Steroid Biochem Mol Biol 52 459-467

[4] Hawes SE(2006)Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492-2502

[5] Lawton TJ(2010)Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers Breast Cancer Res Treat 124 607-617

[6] Bhattacharyya RS(2015)Targeting the androgen receptor in breast cancer Curr Oncol Rep 17 4-89

[7] Krishnan AV(2015)Androgen receptor expression predicts decreased survival in early stage triple-negative breast cancer Ann Surg Oncol 22 82-243

[8] Swami S(2008)Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors J Steroid Biochem Mol Biol 110 236-11

[9] Feldman D(2010)Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells Breast Cancer Res Treat 121 1-4008

[10] Birrell SN(2006)An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen Oncogene 25 3994-15